Our Team Sanofi athletes and Sanofians have a message for you! 👀 There are just 24 days to go until the Olympic and Paralympic Games #Paris2024! All Sanofians will be cheering on our amazing #TeamSanofi! Together, we never settle. 🫶 #IgnitingPotential #WeNeverSettle Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
Sanofi
Fabrication de produits pharmaceutiques
Paris, France 4 026 925 abonnés
À propos
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
- Site web
-
http://www.sanofi.com
Lien externe pour Sanofi
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- + de 10 000 employés
- Siège social
- Paris, France
- Type
- Société cotée en bourse
- Domaines
- vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases et consumer healthcare
Lieux
Employés chez Sanofi
Nouvelles
-
Our commitment to AI is integrated across our entire drug development process. One of the most exciting examples is the development and leveraging of virtual patient populations, more commonly (and fondly) known as “digital twins.” Sanofi’s Global Head of Translational Disease Modeling Thomas Klabunde explains how digital “twinning” works and how it is helping accelerate the R&D process across asthma and other immune-mediated diseases. Read more: http://spkl.io/6040471ZA
-
-
Ever wonder what it's like to be an official #Torchbearer for the Paris 2024 Olympic Torch Relay? We captured some of the most exclusive and exciting moments from behind the scenes with #Paris2024, when the #Olympic Flame Paris 2024 stopped by our site in Neuville-sur-Saône, France 🙌
-
The New England Journal of Medicine (NEJM Group) has published positive Phase 3 results regarding our medicine in children aged 1 to 11 years with eosinophilic esophagitis (#EoE). Read more about how we are working with Regeneron to change the standard of care for young children living with the disease. Read our press release: http://spkl.io/604447BBQ
-
-
Only 1 month to go to the Olympic and Paralympic Games Paris 2024 🔥 Over the past few months, we have shared the inspiring stories of our #TeamSanofi athletes and Sanofians. We want to thank our family, friends, and mentors who inspire us in our pursuit of what’s next – whether in sports or in science. Here is to the people who taught us to never settle. #WeNeverSettle #IgnitingPotential Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
-
We see a future where #mRNA can revolutionize #vaccines and treat genetic diseases. But what does it look like? 🧬 Neha Kaushal chatted with Daniel Anderson, Professor of Chemical Engineering at MIT, about the potential of mRNA therapies and the importance of the drug delivery technologies behind them. 🎥 Check out the full video to learn more about our collaboration! 👉 http://spkl.io/60484A2vO
Partner Spotlight: The Anderson Lab and Sanofi Spark the Future of mRNA Research
-
For a long time, immunoscience and neuroscience have been considered two separate fields of research. We’re exploring the ways these distinct disease areas overlap, especially for #multiplesclerosis. Learn more about how we are unlocking the mysteries of the brain. http://spkl.io/60464AUa0
-
#DYK More than one million people have been diagnosed with #hemophilia worldwide? For many, living with this rare blood disorder means living with ongoing pain, anxiety, and challenges. We know there’s more to be done to help alleviate the burdens this community faces. At #ISTH2024, we’re building on our legacy of innovation in rare blood disorders to help evolve the standard of care in hemophilia across the world. Learn more: http://spkl.io/60414AUaf
-
The Olympic Flame has reached our site in Neuville-sur-Saône, France! 🔥 For over a month now, the Olympic Flame has been traveling across France, and our almost 300 Sanofi Torchbearers are proud to take part in this once-in-a-lifetime opportunity. From sport to science, our partnership with the Olympic and Paralympic Games Paris 2024 is a symbolic representation of our commitment to push boundaries and never settle. Follow us on this journey and relive the highlights here: spkl.io/611004f3on #IgnitingPotential #Paris2024 #WeNeverSettle Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
-
-
New data at the International Society on Thrombosis and Haemostasis (ISTH) Congress reinforce our commitment to bring treatments that could be first- and best-in-class to the #hemophilia community. With a patient-centered approach to developing groundbreaking therapies, we’re working to redefine treatment expectations for this rare blood disorder. Read more about our seven presentations at #ISTH2024: https://lnkd.in/gZ9Auaxk
-
Pages affiliées
Pages similaires
Parcourir les offres d’emploi
Financement
Dernier round
Capital après introduction en Bourse329 024 935,00 $US
Investisseurs